GlobeNewsWire
19 May 2026, 00:12 UTC · 2d ago
Source · https://www.globenewswire.com/news-release/2026/05/19/3297103/673/en/ROSEN-SKILLED-INVESTOR-COUNSEL-Encourages-Regencell-Bioscience-Holdings-Limited-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-RGC.html
Read source
Search tags
Story key points
3 claims · impact-rated
Regencell Bioscience Holdings Limited (RGC) is facing a securities class action lawsuit alleging false and misleading statements regarding market manipulation and volatility. — Allegations of market manipulation and regulatory risk typically increase investor uncertainty and can lead to downward pressure on the stock price.
-0.40The lawsuit claims Regencell was subject to a heightened risk of regulatory and governmental enforcement action. — Potential government enforcement actions create significant legal and financial liability risks for the company.
-0.30The lead plaintiff deadline for the Regencell securities class action is June 23, 2026. — Deadlines for lead plaintiffs signal the progression of litigation, though the immediate price impact is usually low compared to the initial filing.
-0.10Impact vectors
1 dimensions · 9 clusters
Market reaction
0 bid · 0 offered
No stock impact ranking available yet.
No stock impact ranking available yet.
Ticker attribution
Model heads
The company is facing a securities class action lawsuit alleging false and misleading statements and vulnerability to market manipulation.
The company is the subject of a reminder for a securities class action lawsuit.
The company is the subject of a reminder for a securities class action lawsuit.
No ticker relationship head found.
